9th Annual Biomarkers Congress

Drug Design: Johnson & Johnson

Total Score People Score Events Score
48 36 42
Date Event Presentation Speakers
November 3, 2010 DIA’s 8th Annual Canadian Meeting: “Keeping Canada on the Map: Fostering Innovation and Access to Drugs in Canadaâ€� TRACK 2 – Reimbursement - Clinical Trial Design Kostas Trakas
Methodologic Challenges in the Use of Meta-analysis in Comparative Effectiveness Research Jesse A. Berlin
TRACK 2 - Methodological/Data Challenges in Reimbursement Decision Making – Meta-analyses: Drawing insights and value from combining across studies Lesia Babiak
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics Reagent Selection & Management Adrienne Clements-Egan
February 24, 2010 5th Annual Bioanalysis in Clinical Research Towards European Pharma companies best practice on metabolite quantification Philip Timmerman
November 2, 2009 Seventh Annual Strategic Resource Management TABLE 5: End-toEnd R&D Resource Capacity Planning Shannon Diehl
Managing Resources in an Ever-changing Organizational Landscape Shannon Diehl
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Enabling Personalized Medicine through Application of Biomarkers in Clinical Development Nicholas C. Dracopoli
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Enabling Personalized Medicine through Application of Biomarkers in Clinical Development Nicholas C. Dracopoli
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells Enabling Personalized Medicine through Application of Biomarkers in Clinical Development Nicholas C. Dracopoli
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Enabling Personalized Medicine through Application of Biomarkers in Clinical Development Nicholas C. Dracopoli
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine Circulating Tumor Cells: From Enumeration to Comprehensive Characterization Nicholas C. Dracopoli
August 5, 2009 New Frontiers in Cancer Drug Development Translational Medicine: Predictive and Pharmacodynamic Biomarkers in Cancer Drug Development Nicholas C. Dracopoli
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Confirmation of JNJ-38877605 as a selective c-Met kinase inhibitor using quantitative chemical proteomics. Tim Perera
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Modeling Idiosyncratic Hepatotoxicity  Michael McMillian
June 9, 2009 Inaugural The Expanding Impact of New Animal Models in Drug Safety Interlaboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat Michael McMillian
June 9, 2009 Cell and Tissue-Based Assays for HTS Cell-Based Assays in Drug Discovery – So Many Choices, So Little Time Lisa Minor
Chairperson’s Remarks Lisa Minor
Continental Breakfast Breakout Discussions Table Four: Choosing the Right System and Approach for Each Assay Lisa Minor
June 9, 2009 Targeting Pain with Novel Therapeutics The Evolution of Thiazolo[5,4-d]pyrimidines and Related Heterocycles as TRPV1 Antagonists Alec D. Lebsack
Fatty Acid Amide Hydrolase (FAAH): A Look in the Rear-View Mirror, Perspectives on Reversibility J. Guy Breitenbucher
Table Two: Targeting FAAH and Cannabinoids J. Guy Breitenbucher
June 9, 2009 Translating Genomic Knowledge Biomarker Applications in Drug Development Nicholas C. Dracopoli
May 19, 2009 Amorphous Materials Case Study: Effective Strategies in the Characterisation of Amorphous Materials Ilse Weuts
Hot Melt Extrusion/Processing Geert Verreck
April 21, 2009 16th Annual Conference Regulatory Affairs in Central and Eastern Europe Morning coffee and networking Michael McMillian
April 7, 2009 Inaugural HIV Inhibitors Topic 12: The Future of Natural Products in Drug Discovery Bart DeCorte
Featured Presentation: The Discovery of Intelence®, an Important Advance in the Treatment of HIV Bart DeCorte
April 6, 2009 Inaugural THE IMPACT OF OUTSOURCING CHEMISTRY AT THE PROJECT LEVEL Keynote Presentation: From Simple Building Blocks to Strategic Frederik Deroose
Panel Session: A Day in the Life of an Outsourcing Project Manager Frederik Deroose
April 1, 2009 Stability Testing Monitoring stability in line with new requirements for Asean and Anvisa country (zone IV B) Nicoletta Scione
March 23, 2009 Marketing and Salesforce Effectiveness Under the Revised PhRMA Code (Workshop) : Track A : PHRMA GUIDING PRINCIPLES ON DIRECT TO CONSUMER ADVERTISEMENTS Amit B Patel
February 24, 2009 Pharmaceutical Analysis Course Particle characterisation of pharmaceutical dosage forms and their ingredients Arjen Tinke
February 24, 2009 7th Annual Cold Chain Management & Temperature Control Summit PANEL DISCUSSION: A HOLISTIC APPROACH TO GOOD COLD CHAIN FROM THE PHARMACEUTICAL MANUFACTURERS’ PERSPECTIVE Silvia Castellarin
January 27, 2009 Forced Degradation Studies Increase the probability of successfully developing a stable dosage form in a timely fashion through appropriate drug excipient compatibility studies Sara Vrielynck
January 12, 2009 Model Based Drug Development CASE STUDY- IN VITRO/IN VIVO CORRELATION MODELING : Use of Non-Linear Fixed Effects Modeling to succesfully develop an IVIVC, supporting optimal dissolution specification setting for launch An Vermeulen
MODELING TO OPTIMIZE TRIAL DESIGN : Clinical Trial Simulation: An Integration tool to design a POC anti-infective agent trial Hui Holly Kimko
January 5, 2009 High Content Analysis Our Experience with High-Content Screening Using Wound Healing Assay Miroslav Cik
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 2 : Use of WBA (whole body autoradioluminography) to study tissue distribution of compounds in the early and late stages of preclinical trials Katelijne Anciaux,
November 17, 2008 BIO-Europe 2008 Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier-Stage Collaborations? Ted Torphy
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Factoring Takeaways from Recent Deals and Trends into Your Collaborations Strategy Denise M McGinn
October 14, 2008 Crystal Form Selection and Crystallisation of API Using X-ray powder diffraction in crystal form detection Hector Novoa de Armas
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty William N Hait
May 30, 2008 ASCO Annual'08 Meeting professional development-- Mid-Career Changes: Why, How, and When? William Hait
March 25, 2008 TRANSLATIONAL MEDICINE Predictive Response Biomarkers – Theory and Practice Hans Winkler
February 19, 2008 Screening Europe Track A A Comparison of Cell-Based Label-Free Assay Tools Lisa Minor
November 28, 2007 Second Annual Portfolio Management: Creating a Portfolio for Optimal Productivity Nov (28-29) Portfolio & Resource Management - The Intersection of Strategic and Operational Management (08:15-09:00) Rick Bayney
November 27, 2007 Fifth Annual Strategic Resource Management: The Key to Increasing R&D Productivity Nov (27-28) ROUNDTABLE DISCUSSIONS TABLE 3: The Challenges in Creating and Managing Sustainable Portfolio Value (16:45-18:00) Rick Bayney
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Culture, Policy, and Economics of Cancer research and cancer Care: Global Perspective William N Hait
October 25, 2007 Pain Therapeutics Summit 2007 Workshop concludes / Conference registration begins Uri Herzberg
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi as a Predictive Tool (14:20-15:25) Pieter Peeters
RNAi as a Predictive Tool: Chairperson’s Remarks (14:20-14:45) Pieter Peeters
RNAi FOR IN VIVO TARGET VALIDATION (16:30-19:30) Pieter Peeters
RNAi FOR IN VIVO TARGET VALIDATION: Efficient in vivo Knock-down of Genes in the Peripheral/Central Nervous System (17:30-18:00) Pieter Peeters
Roundtable Discussion Topic: In vivo RNAi Screening (07:30-08:30) Pieter Peeters
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) PROCESS OPTIMIZATION VIA ANALYTICS: Isolation of the Drug Substance Impurities at 0.05–0.1% Level Using At-Column Dilution, Mass-Driven Collection, and Comprehensive Automation of the Entire Process (16:05-16:35) Michael Breslav
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS: Discovery and Validation of Biomarkers Affected by Brivanib and Erbitux (11:30-12:00) J. Suso Platero
Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS (11:30-14:00) J. Suso Platero
Third annual Genomic Biomarkers: BIOMARKERS FOR CLINICAL TRIALS: Discovery and Evaluation of Predictive Response Gene Expression Signatures (14:00-14:30) Hans Winkler
Third annual Genomic Biomarkers: BIOMARKERS FOR CLINICAL TRIALS (14:00-16:00) Hans Winkler
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.